Bio Filter Option

Zachary E. Zemlin

Associate

zachary.zemlin@morganlewis.com

Boston Phone +1.617.951.8395 Fax +1.617.341.7701

One Federal St.//Boston, MA 02110-1726//United States

Zachary E. Zemlin represents public and private companies in a broad range of industries, including biotechnology, medical devices, software, and fintech.  Zach has experience counseling clients on mergers and acquisitions, venture capital and other private equity financings, joint ventures, and corporate governance matters. He regularly advises startups through formation and growth strategies, as well as on general corporate and governance matters.

Selected Representations

  • 23andMe in its merger with VG Acquisition Corp., a special purpose acquisition company sponsored by Virgin Group
  • A subsidiary of Babcock Power Inc. in its acquisition of substantially all the assets of Geo-Synthetics LLC
  • CloudBees in its $245 million Series F equity and related debt financing
  • Lola.com in the sale of its workforce and software to Capital One Financial Corp.
  • Turbonomic in its acquisition by IBM
  • SilverCloud in its acquisition by TimeTrad
  • Descartes Systems Group Inc. in its acquisition of GreenMile
  • Vets First Choice in its merger with the animal health division of Henry Schein to form Covetrus
  • Fox Auto in its sale of the largest US privately-held vehicle rental business to French public company Europcar
  • MDI Group in its sale to Motion Recruitment Partners
  • AcadiaSoft in its sale of a minority interest to London Stock Exchange
  • CloudBees in its acquisition of Rollout.io
  • CloudBees in connection with its acquisition of Electric Cloud
  • Lola.com in its $37 million Series C financing
  • Advance Publications in its acquisition of 1010data
  • Citrix Systems, Inc. in its acquisition of Cedexis
  • CloudBees in connection with its $62 million growth funding transactions and its acquisition of Codeship
  • Collinson Group in its acquisition of assets from Linkable Networks
  • eBay in the sale of its eBay India Business to Flipkart and its $500 million investment in Flipkart
  • Navient Solutions LLC in its asset sale, licensing, and services transaction with First Data Resources LLC
  • Rhythm Pharmaceuticals in its $137 million initial public offering and $174 million follow on public offering
  • Private equity firm The Wicks Group of Companies in its leveraged acquisition of Invo HealthCare

Admissions

  • Massachusetts

Education

  • Cornell Law School, 2014, J.D.
  • Cornell University, 2011, B.A.

Sectors

  • Life Sciences
  • Technology
  • Fintech

Services

  • Corporate, Finance & Investment Management
  • Mergers & Acquisitions
  • Capital Markets & Public Companies
  • Emerging Business & Technology

Regions

  • North America

News

4/14/2022 - Morgan Lewis Advises Blockchain Distribution Network bloXroute in $70M Series B Funding
2/4/2021 - Morgan Lewis Represents 23andMe in Agreement to Merge with Virgin Group’s VG Acquisition
9/24/2019 - Morgan Lewis Advises Proteon Therapeutics in Combination with ArTara
2/11/2019 - Morgan Lewis Represents Vets First Choice in Merger with Henry Schein
4/24/2018 - Morgan Lewis Represents Vets First Choice in Henry Schein, Inc. Animal Health Business Merger
7/19/2017 - Morgan Lewis Advises Vets First Choice in $223 Million Investment
4/12/2016 - Morgan Lewis advises Tempur Sealy International on $1.1B New Credit Facilities